Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
by Wu J, Jia S, Xu B, Yao X, Shao J, Yao J, Cen D and Yao X (2023). Front. Pharmacol. 14:1157200. doi: 10.3389/fphar.2023.1157200
Due to a production error, an author name was incorrectly spelled as “Benghong Xu”. The correct spelling is “Benhong Xu”. The publisher apologizes for this mistake.
The original version of this article has been updated.
Keywords: bicyclol, NAFLD, NASH, proteomics, multiple pathways
Citation: Frontiers Production Office (2023) Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice. Front. Pharmacol. 14:1204546. doi: 10.3389/fphar.2023.1204546
Received: 12 April 2023; Accepted: 12 April 2023;
Published: 20 April 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org